Mandate

Vinge has advised the owners of Swedish Oat Fiber in conjunction with the sale of the company to Naturex

November 14, 2017 Banking and Finance

Swedish Oat Fiber has a leading international market position as a producer of oat beta glucan, dietary fiber, oat oils and oat proteins for use in the food, health, cosmetics and animal food industries. The company’s head office and manufacturing facility is situated in Bua outside Gothenburg.

Naturex distributes, manufactures and markets natural special ingredients for the food, health and cosmetics industries. Naturex is listed on Euronext Paris and has its head office in Avignon, France, and employs 1 700 people over the entire world. In 2016, the group’s turnover was EUR 404.4 million. The acquisition accords with Naturex’s strategy to accelerate the development of its special production portfolio and will provide significant synergies with their business development model. Swedish Oat Fiber will also contribute to strengthening Naturex’s market position within the natural food segment.

Vinge’s team consisted of partner Björn Mullaart together with, among others, associates Fredrik Christiansson, Niklas Törnell and Freja Ljungdell Kristensen.

Livingstone acted as the financial advisor to Swedish Oat Fiber in the sales process.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised SBP Kredit AB (publ) in connection a securitisation with a Nordic bank as senior lender

The agreement covers a total amount of SEK 1 billion and creates conditions for significantly increased lending capacity. The agreement has been structured in accordance with the EU Securitisation Regulation and enables qualified loans to be continuously transferred to a special purpose vehicle within the SBP group.
September 14, 2026